Teleflex Incorporated (TFX) Valuation

Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, ma...

Teleflex Incorporated (TFX) currently trades at a P/E ratio of 28.21 (historical range: 25.81–49.22, median: 36.27), placing it at the 20th percentile — below its historical average, P/S ratio of 3.33 (range: 1.41–3.89, 90th percentile — expensive relative to its history), EV/EBITDA of 418.28 (range: 23.50–421.61, 98th percentile).

Over the historical period (2024-08-30 to 2026-08-28), Teleflex Incorporated's P/E ratio has contracted by 18% over the observed period (from an average of 36.3 to 29.7).

Teleflex Incorporated appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.

Historical Valuation Metrics

MetricCurrentMinMedianMaxPercentileAssessment
P/E Ratio28.2125.8136.2749.2220thbelow its historical average
P/S Ratio3.331.412.113.8990thexpensive relative to its history
EV/EBITDA418.2823.5059.85421.6198thexpensive relative to its history
FCF Yield0.000.000.010.0826thabove its historical average
Current Price: $142.05
Market Cap: $6.0B
Sector: Healthcare